Modelling US health equity impacts of emicizumab for severe haemophilia A: aggregate distributional cost-effectiveness analysis.

BMJ Open · 2025 · PMC12421612 · PMID 40930552

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Similarly, broader societal impacts, including work productivity loss, caregiver burden and education disruptions, were not accounted for, which may be significant for PwSHA.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.